Kristin Macarthur, MD
Gastroenterology · Branford, CTNPI 1225357809
Payments from drug & device makers
Across 427 payments — averaging $19.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Johnson & Johnson$606
- Bristol Myers Squibb$381
- Pfizer$318
- plus $2K from 27 others
What the payments were for
- Food & beverage$8,04699%
- Education$801%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 83 | $1,657 |
| AbbVie(2 entities) | 96 | $1,638 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 59 | $1,062 |
| Johnson & Johnson(2 entities) | 31 | $606 |
| Bristol Myers Squibb | 19 | $381 |
| Pfizer | 18 | $318 |
| Gilead | 18 | $289 |
| Ardelyx, Inc. | 10 | $236 |
| QOL Medical, LLC | 7 | $203 |
| Ferring Pharmaceuticals Inc. | 12 | $201 |
| Ironwood Pharmaceuticals, Inc | 9 | $173 |
| Merck | 7 | $114 |
| Phathom Pharmaceuticals, Inc. | 5 | $108 |
| Braintree Laboratories, Inc. | 6 | $107 |
| Vivus LLC | 5 | $102 |
| Nestle Healthcare Nutrition Inc. | 4 | $98 |
| Redhill Biopharma Inc. | 5 | $90 |
| Madrigal Pharmaceuticals | 3 | $89 |
| Boston Scientific | 2 | $87 |
| Aimmune Therapeutics, Inc. | 3 | $86 |
| UCB, Inc. | 4 | $69 |
| Daiichi Sankyo Inc. | 4 | $64 |
| Lilly USA, LLC | 3 | $64 |
| Celltrion USA Inc. | 3 | $44 |
| Alfasigma USA, Inc. | 2 | $36 |
| Sanofi | 1 | $33 |
| Shire North American Group Inc | 2 | $32 |
| Exact Sciences | 1 | $30 |
| Evoke Pharma, Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| AMAG Pharmaceuticals, Inc. | 1 | $22 |
| Medtronic | 1 | $21 |
| Intercept Pharmaceuticals, Inc. | 1 | $20 |
How this compares
$8,126 in reported general payments places this provider in the 70th percentile of 326 gastroenterology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 13 | $354,426 |
| CreonLipase/Protease/Amylase | 47 | $131,227 |
| LinzessLinaclotide | 84 | $95,548 |
| MotegrityPrucalopride Succinate | 28 | $39,439 |
| TrulancePlecanatide | 16 | $17,991 |
| Dexlansoprazole DrDexlansoprazole | 26 | $8,774 |
| MovantikNaloxegol Oxalate | 11 | $6,522 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 102 | $6,381 |
| Mesalamine | 13 | $4,836 |
| Pantoprazole Sodium | 272 | $3,835 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 22 | $3,569 |
| Omeprazole | 119 | $1,801 |
| Mesalamine ErMesalamine | 12 | $1,554 |
| Ondansetron OdtOndansetron | 32 | $887 |
| Famotidine | 59 | $720 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $606 | $354,42613 claims |
| AbbVieCreon, Linzess | $1,638 | $226,775131 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $1,657 | $39,43928 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $1,062 | $17,99116 claims |
| Redhill Biopharma Inc.Movantik | $90 | $6,52211 claims |
| Braintree Laboratories, Inc.Sutab | $107 | $3,56922 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 326 gastroenterology providers in Connecticut.
Other gastroenterology in Branford
- Pramod MistryNew Haven$6M
- Salam ZakkoBristol$2.7M
- Paul FeuerstadtHamden$1.4M
- Angelo ParedesMiddletown$1.3M
- James FrestonFarmington$778K
- Jill GaidosNew Haven$750K
- Houman RezaizadehFarmington$720K
- James BoyerNew Haven$648K
- Guadalupe Garcia TsaoNew Haven$555K
- Loren LaineWest Haven$485K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.